Two University of Manchester scientists have been shortlisted for the prestigious BBSRC Innovator of the Year award. Both Dr Sheena Cruickshank and Dr Andrew Almond from the Faculty of Life Sciences have been nominated.
The BBSRC Innovator of the Year will be awarded on the 18 May at the Fostering Innovation event in London. The award recognises scientists who have been able to harness the full potential of their research leading to breakthroughs in their respective fields. An award nomination is a recognition of a scientist’s excellent work and effort.
Dr Andrew Almond received his nomination in helping to pioneer the C4X venture. C4X is a spin-out company that uses a new approach for for 3D modelling of specific structures with high accuracy. This modelling has helped to develop new and effective drug targets and does so in a much more efficient way; sometimes saving up to 90% of the normal production costs. The company is now estimated to be worth £31 million.
On receiving the nomination, Dr Almond said:
“I was delighted to receive the news that I had been shortlisted for BBSRC Innovator of the Year and surprised by the very positive feedback from the review panel. C4X Discovery, now listed on the London Stock Exchange, is building the world’s most productive drug discovery engine and its recent ground breaking R&D in the areas of addiction, COPD, inflammation and diabetes are poised to deliver substantial patient benefits. It is testament to the University of Manchester’s world leading research environment and its assiduous support for innovation and commercialisation.”
Dr Sheena Cruickshank has received her nomination on the basis of her work, in raising awareness and involving the public in her research around infection and immunology, in both local and global communities. Sheena studies neglected tropical diseases and her work with international populations of people now based in the UK has directed and informed her research which now focuses on ways to better diagnose and monitor infection. Her work identified a need to develop science resources that would remove barriers to accessing healthcare, enabling dialogue and discussion. These resources have been used in Bolton College and more recently in Madagascar. In addition in response to concerns from international communities about allergies she worked with the public, teams of scientists and the Royal Society of Biology and British Society for Immunology to create the #BritainBreathing app which uses citizen science to further research into seasonal allergies.
On receiving the nomination, Dr Cruickshank said:
“I was thrilled to receive the news that I had been shortlisted as I am passionate about sharing my research with the public and believe this is a vital part of a scientist’s role in society. Working with the public has been vital to my research and really driven its direction and shaped its content. Hearing people’s own reflections on infections and the barriers to healthcare is deeply moving and I have been privileged to work these people as well as my amazing collaborators who have enabled this work. This project is one of many that reflect the University’s commitment to Social Responsibility.”